2025-01-21 2026-01-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 16197673 bus:FullAccounts 2025-01-21 2026-01-31 16197673 bus:Micro-entities 2025-01-21 2026-01-31 16197673 bus:AuditExempt-NoAccountantsReport 2025-01-21 2026-01-31 16197673 bus:SmallCompaniesRegimeForAccounts 2025-01-21 2026-01-31 16197673 bus:PrivateLimitedCompanyLtd 2025-01-21 2026-01-31 16197673 2025-01-21 2026-01-31 16197673 2026-01-31 16197673 bus:RegisteredOffice 2025-01-21 2026-01-31 16197673 core:WithinOneYear 2026-01-31 16197673 core:AfterOneYear 2026-01-31 16197673 2024-01-21 16197673 bus:Director1 2025-01-21 2026-01-31 16197673 bus:Director1 2026-01-31 16197673 bus:CompanySecretary1 2025-01-21 2026-01-31 16197673 bus:LeadAgentIfApplicable 2025-01-21 2026-01-31 16197673 2025-01-20 16197673 core:CostValuation core:Non-currentFinancialInstruments 2026-01-31 16197673 core:CostValuation core:Non-currentFinancialInstruments 2025-01-20 16197673 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-01-31 16197673 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16197673 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16197673 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16197673 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-01-31 16197673 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-01-31 16197673 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16197673 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16197673 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 16197673 core:Non-currentFinancialInstruments 2026-01-31 16197673 core:Non-currentFinancialInstruments 2025-01-20 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 16197673
England and Wales

 

 

 


Unaudited Financial Statements

for the period ended 31 January 2026

for

MATT E CLINICAL CODER U.K LTD

 
 
2026
£
 
Current assets 2,116 
Creditors: amount falling due within one year (2,016)
Net current assets/(liabilities) 100 
Total assets less current liabilities 100 
Net assets/(liabilities) 100 
 
Capital and reserves 100 
 



Notes to the Accounts
Statutory Information
Matt E Clinical Coder U.K Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 16197673, registration address 27 Green Street, March, PE15 9DU, England.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the period was 1.
3.

Disclosure note

As at the year end 31 Jan 2026, the Director owed the Company £1,878.83. The loan is non-interest bearing, unsecured and has no set repayment terms. 

Director's Responsibilities:
  1. For the period ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:


---------------------------------------------
Matthew Edward Eady
Director

Date approved: 21 October 2026
1